Literature DB >> 3839848

A nonlinear multiple regression program, MULTI2 (BAYES), based on Bayesian algorithm for microcomputers.

K Yamaoka, T Nakagawa, H Tanaka, M Yasuhara, K Okumura, R Hori.   

Abstract

A nonlinear multiple regression analysis program MULTI2(BAYES) was developed for microcomputers. The Bayesian algorithm which is incorporated in MULTI2 (BAYES) combines the insufficient individual patient data (individual data) with the pharmacokinetic parameters published in literatures (population parameters) to predict the plasma time course of the patient. The program is written in the minimum Microsoft BASIC commands alone to be executable on many personal computers without any modification. The numbers of parameters to estimate, independent variables and dependent variables are not restricted in use of MULTI2(BAYES). The pharmacokinetic models are defined as one pleases by the user. The four nonlinear least squares algorithms, i.e. Gauss-Newton method, damping Gauss-Newton method, modified Marquardt method by Fletcher and simplex method can be selected at user's option. MULTI2(BAYES) calculates the confidence limits of time courses at 95% significant level.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839848     DOI: 10.1248/bpb1978.8.246

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  14 in total

Review 1.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

2.  Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.

Authors:  Takafumi Nakano; Yoshihiko Nakamura; Tohru Takata; Keiichi Irie; Kazunori Sano; Osamu Imakyure; Kenichi Mishima; Koujiro Futagami
Journal:  Int J Clin Pharm       Date:  2016-04-28

3.  The initial distribution volume of glucose and cardiac output after haemorrhage in dogs.

Authors:  Y Shimodate; H Ishihara; A Matsuki
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

4.  Pharmacokinetic analysis of an oral sustained-release diltiazem preparation using multifraction absorption models.

Authors:  K Murata; K Noda
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

5.  Predictive performance of the Bayesian analysis: effects of blood sampling time, population parameters, and pharmacostatistical model.

Authors:  Y Tanigawara; I Yano; K Kawakatsu; K Nishimura; M Yasuhara; R Hori
Journal:  J Pharmacokinet Biopharm       Date:  1994-02

6.  Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route.

Authors:  T Uno; T Kazui; Y Suzuki; H Hashimoto; K Suzuki; B A Muhammad
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

7.  Population pharmacokinetics of phenytoin in Singapore Chinese.

Authors:  E Chan; T Y Ti; H S Lee
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Effects of anti-malarial drugs on the electrocardiographic QT interval modelled in the isolated perfused guinea pig heart system.

Authors:  Atsushi Kinoshita; Harumi Yamada; Hajime Kotaki; Mikio Kimura
Journal:  Malar J       Date:  2010-11-10       Impact factor: 2.979

Review 9.  An updated comparison of drug dosing methods. Part II: Theophylline.

Authors:  S M Erdman; K A Rodvold; R D Pryka
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

10.  Does the initial distribution volume of glucose reflect plasma volume after haemorrhage in dogs?

Authors:  H Koh; H Ishihara; A Miyahara; S Takahashi; A Matsuki
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.